Vincent has over 10 years of experience in the healthcare sector. Vincent started his career at Bain & Company before joining 3i’s healthcare team. Prior to joining ArchiMed, Vincent was JS Bio’s Managing Director, a leading pathology laboratories group in France. At 3i and JS Bio, Vincent was involved in more than 10 transactions in the healthcare sector.

Vincent graduated from l’Ecole Nationale des Ponts et Chaussées as an Engineer and holds a MSc from the University of Berkeley.

With over 15 years of private equity experience in the US, Asia, UK and France, Robin has been particularly focused on the healthcare sector, where he completed a number of deals as both a minority and a majority partner.

Robin’s extensive international private equity experience includes Brown Brothers Harriman, Baring Private Equity Partners, TCR Capital and most recently Universities Superannuation Scheme.

Within the healthcare sector, Robin completed a number of noteworthy transactions, including Trescal, Labco and IPP. Robin also sits on the board of Menalabs, the leading diagnostic group in the Middle East.

Robin graduated from the School of Foreign Service at Georgetown University and holds an MBA from INSEAD.

Denis has 20 years of experience in the healthcare sector. After working as a veterinarian and as a strategy consultant at ATKearney, Denis joined 3i where he became global head of their healthcare practice, leading the firm’s healthcare investment and portfolio activity in Europe, North America and Asia.

Denis has been actively involved in the strategic growth and development of companies across all major healthcare sectors. He has served on the board of directors of more than 15 firms, including 10 public and private healthcare companies, such as Quintiles, Labco, iPP, Vétoquinol, Neftys Pharma, Carso, Bioprofile or Cair.

Denis is a member of the Institut Montaigne, a French think tank.

Denis graduated from the French Veterinary University of Lyon and holds an MBA from HEC Paris.